Related Experiment Videos
Chemotherapy for ovarian germ cell tumours
European Journal of Cancer (Oxford, England : 1990)
|April 1, 1996
Summary
The POMB/ACE chemotherapy regimen shows high efficacy in treating metastatic ovarian germ cell tumors, with excellent survival rates and successful fertility-sparing outcomes. This treatment offers a favorable balance of low toxicity and high success for patients.
Area of Science:
- Oncology
- Gynecologic Oncology
- Chemotherapy
Background:
- Metastatic ovarian germ cell tumors (OGCT) require effective treatment regimens.
- Assessing the long-term outcomes and safety of chemotherapy is crucial for patient management.
Purpose of the Study:
- To evaluate the efficacy and safety of the POMB/ACE chemotherapy regimen in patients with newly diagnosed metastatic OGCT.
- To assess long-term survival, relapse rates, and reproductive outcomes following treatment.
Main Methods:
- Retrospective analysis of 59 patients with newly diagnosed metastatic OGCT treated with POMB/ACE chemotherapy.
- Follow-up data including survival, relapse, salvage therapy, and pregnancy outcomes were collected.
Main Results:
- The 3-year survival rate was 87.8%. No relapses occurred beyond 3 years post-treatment.
- Primary drug resistance was observed in 7% of patients, with a 7% relapse rate.
- Successful pregnancies were reported in 42% of women who underwent fertility-sparing surgery and chemotherapy, with no congenital abnormalities.
Conclusions:
- The POMB/ACE regimen is an effective treatment for metastatic OGCT, comparable to other published regimens.
- It demonstrates a favorable balance of low toxicity and high success rates, including positive reproductive outcomes.